Ophthalmic viscoelastic devices (OVD) are tools used in modern cataract surgeries. They are non-active, clear, and gel-like solutions with viscous and elastic properties. OVDs mainly contain Sodium Hyaluronate, Chondroitin Sulfate, and Hydroxypropyl Methylcellulose. These substances cover and protect the intraocular tissues, ocular structures, and improve visualization. Major role of OVDs is to create and maintain volume in the anterior chamber of the eye, and protect the corneal endothelium during the ophthalmic procedure.
Increasing prevalence of ophthalmic diseases such as glaucoma, and cataract is expected to drive the ophthalmic viscoelastic devices (OVD) market growth. For instance, in November 2014, the American Academic of Ophthalmology (AAO) studied the global prevalence of glaucoma and projections of glaucoma burden up to 2040. According to AAO, in 2013, there were an estimated 64.3 million people diagnosed with glaucoma. Moreover, AAO also stated that the number is expected to increase in future.
- This report provides in-depth analysis of the global ophthalmic viscoelastic devices market, market size (US$ Mn), and compound annual growth rate (CAGR %) over the forecast period (2019 – 2027), considering 2018, as the base year
- It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrixes for this market
- This study also provides key insights about market drivers, restraints, opportunities, new technology launches or approvals, market trends, regional outlook, and competitive strategies adopted by leading players
- It profiles leading players in the global ophthalmic viscoelastic devices market based on the following parameters – company overview, financial performance, technology portfolio, geographical presence, distribution strategies, key developments, and strategies
- Key players covered as a part of this study include Johnson & Johnson, Rumex International Co., Bausch & Lomb Incorporated., Ophtechnics Unlimited, Truviz Ophthalmic., Beye, LLC, Carl Zeiss Meditec AG, Precision Lens, Iso Clear (Pty) Ltd., and Neu Micromed International Pvt. Ltd
- Insights from this report would allow marketers and management authorities of companies to make informed decision with respect to future technology launches, governmental initiatives, technological up-gradation, market expansions, and marketing tactics
- The global ophthalmic viscoelastic devices market report caters to various stakeholders in this market, including investors, technology manufacturers, distributors, and suppliers in the global ophthalmic viscoelastic devices industry, research and consulting firms, new entrants, and financial analysts
-
- Dispersive Ophthalmic Viscoelastic Devices
- Cohesive Ophthalmic Viscoelastic Devices
-
- Cataract Surgery
- Glaucoma Surgery
- Vitreoretinal Surgery
- Corneal Transplantation Surgery
- Others
-
- Sodium Hyaluronate
- Chondroitin Sulfate
- Hydroxypropyl Methylcellulose
-
- Ophthalmic Clinics
- Hospitals
- Academic and Research Institutes
-
- North America
- Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East & Africa
- GCC Countries
- Israel
- Rest of Middle East & Africa
-
- Johnson & Johnson
- Rumex International Co.
- Bausch & Lomb Incorporated.
- Ophtechnics Unlimited
- Truviz Ophthalmic
- Beye, LLC
- Carl Zeiss Meditec AG
- Precision Lens
- Iso Clear (Pty) Ltd.
- Neu Micromed International Pvt. Ltd
